Prevalence and correlates of comorbidity 8 years after a first psychotic episode

被引:21
作者
Farrelly, S.
Harris, M. G.
Henry, L. P.
Purcell, R.
Prosser, A.
Schwartz, O.
Jackson, H.
McGorry, P. D.
机构
[1] Univ Melbourne, ORYGEN Res Ctr, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Psychiat, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia
关键词
first episode; psychosis; comorbidity; substance abuse; axis I; outcome;
D O I
10.1111/j.1600-0447.2006.00922.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: While rates and correlates of comorbidity have been investigated in the early course of psychosis, little is known about comorbidity in the medium-to-longer term or its relationship with outcome. Method: A total of 182 first-episode psychosis (FEP) patients who met DSM-IV criteria for a current psychotic disorder 8 years after index presentation were grouped according to concurrent comorbidity [no concurrent axis I disorder; concurrent substance use disorder (SUD); other concurrent axis I disorder; concurrent SUD and other axis I disorder]. Outcomes were compared between groups controlling for relevant covariates. Results: As much as 39% met criteria for one or more concurrent axis 1 diagnoses. Comorbidity was associated with greater severity of general psychopathology, but not with measures of functioning, treatment or negative symptoms. Conclusion: Specific combinations of comorbid disorders may influence patterns of psychotic symptomatology. Routine examination of axis I disorders is warranted in the ongoing management of psychosis.
引用
收藏
页码:62 / 70
页数:9
相关论文
共 43 条
[11]   Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders [J].
Cassano, GB ;
Pini, S ;
Saettoni, M ;
Rucci, P ;
Dell'Osso, L .
JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (02) :60-68
[12]   Lifetime prevalence and pseudocomorbidity in psychiatric research [J].
Chmura Kraemer, Helena ;
Wilson, Kimberly A. ;
Hayward, Chris .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (06) :604-608
[13]   The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder [J].
Cosoff, SJ ;
Hafner, RJ .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1998, 32 (01) :67-72
[14]   Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes [J].
Dixon, L .
SCHIZOPHRENIA RESEARCH, 1999, 35 :S93-S100
[15]   Comorbid conditions in schizophrenia [J].
Fenton, WS .
CURRENT OPINION IN PSYCHIATRY, 2001, 14 (01) :17-23
[16]  
First M, 2016, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P)
[17]  
Fleiss J.L., 1986, The Design and Analysis of Clinical Experiments
[18]  
GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148
[19]   Cannabis use and misuse prevalence among people with psychosis [J].
Green, B ;
Young, R ;
Kavanagh, D .
BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 :306-313
[20]   Relapse in schizophrenia: Is there a relationship to substance abuse? [J].
Gupta, S ;
Hendricks, S ;
Kenkel, AM ;
Bhatia, SC ;
Haffke, EA .
SCHIZOPHRENIA RESEARCH, 1996, 20 (1-2) :153-156